MS-DRG 917

Principal Diagnosis - Pdx

• M1A.10X0 Lead-induced chronic gout, unspecified site, without tophus (tophi)
• M1A.10X1 Lead-induced chronic gout, unspecified site, with tophus (tophi)
• M1A.1110 Lead-induced chronic gout, right shoulder, without tophus (tophi)
• M1A.1111 Lead-induced chronic gout, right shoulder, with tophus (tophi)
• M1A.1120 Lead-induced chronic gout, left shoulder, without tophus (tophi)
• M1A.1121 Lead-induced chronic gout, left shoulder, with tophus (tophi)
• M1A.1190 Lead-induced chronic gout, unspecified shoulder, without tophus (tophi)
• M1A.1191 Lead-induced chronic gout, unspecified shoulder, with tophus (tophi)
• M1A.1210 Lead-induced chronic gout, right elbow, without tophus (tophi)
• M1A.1211 Lead-induced chronic gout, right elbow, with tophus (tophi)
• M1A.1220 Lead-induced chronic gout, left elbow, without tophus (tophi)
• M1A.1221 Lead-induced chronic gout, left elbow, with tophus (tophi)
• M1A.1290 Lead-induced chronic gout, unspecified elbow, without tophus (tophi)
• M1A.1291 Lead-induced chronic gout, unspecified elbow, with tophus (tophi)
• M1A.1310 Lead-induced chronic gout, right wrist, without tophus (tophi)
• M1A.1311 Lead-induced chronic gout, right wrist, with tophus (tophi)
• M1A.1320 Lead-induced chronic gout, left wrist, without tophus (tophi)
• M1A.1321 Lead-induced chronic gout, left wrist, with tophus (tophi)
• M1A.1390 Lead-induced chronic gout, unspecified wrist, without tophus (tophi)
• M1A.1391 Lead-induced chronic gout, unspecified wrist, with tophus (tophi)
• M1A.1410 Lead-induced chronic gout, right hand, without tophus (tophi)
• M1A.1411 Lead-induced chronic gout, right hand, with tophus (tophi)
• M1A.1420 Lead-induced chronic gout, left hand, without tophus (tophi)
• M1A.1421 Lead-induced chronic gout, left hand, with tophus (tophi)
• M1A.1490 Lead-induced chronic gout, unspecified hand, without tophus (tophi)
• M1A.1491 Lead-induced chronic gout, unspecified hand, with tophus (tophi)
• M1A.1510 Lead-induced chronic gout, right hip, without tophus (tophi)
• M1A.1511 Lead-induced chronic gout, right hip, with tophus (tophi)
• M1A.1520 Lead-induced chronic gout, left hip, without tophus (tophi)
• M1A.1521 Lead-induced chronic gout, left hip, with tophus (tophi)
• M1A.1590 Lead-induced chronic gout, unspecified hip, without tophus (tophi)
• M1A.1591 Lead-induced chronic gout, unspecified hip, with tophus (tophi)
• M1A.1610 Lead-induced chronic gout, right knee, without tophus (tophi)
• M1A.1611 Lead-induced chronic gout, right knee, with tophus (tophi)
• M1A.1620 Lead-induced chronic gout, left knee, without tophus (tophi)
• M1A.1621 Lead-induced chronic gout, left knee, with tophus (tophi)
• M1A.1690 Lead-induced chronic gout, unspecified knee, without tophus (tophi)
• M1A.1691 Lead-induced chronic gout, unspecified knee, with tophus (tophi)
• M1A.1710 Lead-induced chronic gout, right ankle and foot, without tophus (tophi)
• M1A.1711 Lead-induced chronic gout, right ankle and foot, with tophus (tophi)
• M1A.1720 Lead-induced chronic gout, left ankle and foot, without tophus (tophi)
• M1A.1721 Lead-induced chronic gout, left ankle and foot, with tophus (tophi)
• M1A.1790 Lead-induced chronic gout, unspecified ankle and foot, without tophus (tophi)
• M1A.1791 Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi)
• M1A.18X0 Lead-induced chronic gout, vertebrae, without tophus (tophi)
• M1A.18X1 Lead-induced chronic gout, vertebrae, with tophus (tophi)
• M1A.19X0 Lead-induced chronic gout, multiple sites, without tophus (tophi)
• M1A.19X1 Lead-induced chronic gout, multiple sites, with tophus (tophi)
• T36.0X1A Poisoning by penicillins, accidental (unintentional), initial encounter
• T36.0X2A Poisoning by penicillins, intentional self-harm, initial encounter
• T36.0X3A Poisoning by penicillins, assault, initial encounter
• T36.0X4A Poisoning by penicillins, undetermined, initial encounter
• T36.0X5A Adverse effect of penicillins, initial encounter
• T36.1X1A Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), initial encounter
• T36.1X2A Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter
• T36.1X3A Poisoning by cephalosporins and other beta-lactam antibiotics, assault, initial encounter
• T36.1X4A Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, initial encounter
• T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
• T36.2X1A Poisoning by chloramphenicol group, accidental (unintentional), initial encounter
• T36.2X2A Poisoning by chloramphenicol group, intentional self-harm, initial encounter
• T36.2X3A Poisoning by chloramphenicol group, assault, initial encounter
• T36.2X4A Poisoning by chloramphenicol group, undetermined, initial encounter
• T36.2X5A Adverse effect of chloramphenicol group, initial encounter
• T36.3X1A Poisoning by macrolides, accidental (unintentional), initial encounter
• T36.3X2A Poisoning by macrolides, intentional self-harm, initial encounter
• T36.3X3A Poisoning by macrolides, assault, initial encounter
• T36.3X4A Poisoning by macrolides, undetermined, initial encounter
• T36.3X5A Adverse effect of macrolides, initial encounter
• T36.4X1A Poisoning by tetracyclines, accidental (unintentional), initial encounter
• T36.4X2A Poisoning by tetracyclines, intentional self-harm, initial encounter
• T36.4X3A Poisoning by tetracyclines, assault, initial encounter
• T36.4X4A Poisoning by tetracyclines, undetermined, initial encounter
• T36.4X5A Adverse effect of tetracyclines, initial encounter
• T36.5X1A Poisoning by aminoglycosides, accidental (unintentional), initial encounter
• T36.5X2A Poisoning by aminoglycosides, intentional self-harm, initial encounter
• T36.5X3A Poisoning by aminoglycosides, assault, initial encounter
• T36.5X4A Poisoning by aminoglycosides, undetermined, initial encounter
• T36.5X5A Adverse effect of aminoglycosides, initial encounter
• T36.6X1A Poisoning by rifampicins, accidental (unintentional), initial encounter
• T36.6X2A Poisoning by rifampicins, intentional self-harm, initial encounter
• T36.6X3A Poisoning by rifampicins, assault, initial encounter
• T36.6X4A Poisoning by rifampicins, undetermined, initial encounter
• T36.6X5A Adverse effect of rifampicins, initial encounter
• T36.7X1A Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), initial encounter
• T36.7X2A Poisoning by antifungal antibiotics, systemically used, intentional self-harm, initial encounter
• T36.7X3A Poisoning by antifungal antibiotics, systemically used, assault, initial encounter
• T36.7X4A Poisoning by antifungal antibiotics, systemically used, undetermined, initial encounter
• T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial encounter
• T36.8X1A Poisoning by other systemic antibiotics, accidental (unintentional), initial encounter
• T36.8X2A Poisoning by other systemic antibiotics, intentional self-harm, initial encounter
• T36.8X3A Poisoning by other systemic antibiotics, assault, initial encounter
• T36.8X4A Poisoning by other systemic antibiotics, undetermined, initial encounter
• T36.8X5A Adverse effect of other systemic antibiotics, initial encounter
• T36.91XA Poisoning by unspecified systemic antibiotic, accidental (unintentional), initial encounter
• T36.92XA Poisoning by unspecified systemic antibiotic, intentional self-harm, initial encounter
• T36.93XA Poisoning by unspecified systemic antibiotic, assault, initial encounter
• T36.94XA Poisoning by unspecified systemic antibiotic, undetermined, initial encounter
• T36.95XA Adverse effect of unspecified systemic antibiotic, initial encounter
• T37.0X1A Poisoning by sulfonamides, accidental (unintentional), initial encounter
• T37.0X2A Poisoning by sulfonamides, intentional self-harm, initial encounter